Literature DB >> 3029984

Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector.

S Inumaru, P Roy.   

Abstract

DNA representing RNA segment 2 of bluetongue virus (BTV) serotype 10, corresponding to the gene that codes for the BTV neutralization antigen VP2, has been inserted into a baculovirus transfer vector in lieu of the 5' coding region of the polyhedrin gene of Autographa californica nuclear polyhedrosis virus (AcNPV). After cotransfection of Spodoptera frugiperda cells with wild-type AcNPV DNA in the presence of the derived recombinant transfer vector DNA, polyhedrin-negative recombinant baculoviruses were recovered. When S. frugiperda cells were infected with one of these recombinant viruses, a protein that was similar in size and antigenic properties to the BTV VP2 protein was synthesized. Antibodies raised in mice or rabbits to the baculovirus expressed VP2 protein neutralized the infectivity of BTV-10 virus and to lesser extents BTV serotype 11 and 17 viruses but not BTV-13 virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029984     DOI: 10.1016/0042-6822(87)90289-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

Review 1.  Expression of eukaryotic genes in insect cultures.

Authors:  M J Fraser
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

2.  Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death.

Authors:  Clifton P Drew; Ian A Gardner; Christie E Mayo; Eiko Matsuo; Polly Roy; N James MacLachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

3.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

4.  Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.

Authors:  Junzheng Du; Bishnupriya Bhattacharya; Theresa H Ward; Polly Roy
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  Differential serologic responses to reassortant bluetongue viruses recovered from a bull.

Authors:  M S Maia; B I Osburn
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.

Authors:  S S Hassan; P Roy
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

Authors:  T J French; J J Marshall; P Roy
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Recombinant virus vaccine for bluetongue disease in sheep.

Authors:  P Roy; T Urakawa; A A Van Dijk; B J Erasmus
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Expression of largest RNA segment and synthesis of VP1 protein of bluetongue virus in insect cells by recombinant baculovirus: association of VP1 protein with RNA polymerase activity.

Authors:  T Urakawa; D G Ritter; P Roy
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

10.  The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.

Authors:  Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.